Cross-talk Between Retinoic Acid and STAT3 Signaling Pathways in Acute Promyelocytic Leukemia

References

• Chen, Z., Tong, J.H., Dong, S., Zhu, J., Wang, Z.Y. and Chen, Si. (1996) "Retinoic acid regulatory pathways, chromosomal trans-locations, and acute promyelocytic leukemia", Genes Chromosomes Cancer 15, 147–156.
   PubMed Web of Science ®Google Scholar
• Dong, S., Geng, J.P., Tong, LH., Wu, Y., Cai, J.R., Sun, G.L., Chen, SR., Wang, Z.Y., Larsen, C.J., Berger, R., el at (1993) "Breakpoint clusters of the PML gene in acute promyelocytic leukemia: primary Structure of the reciprocal products of the PML-RARA gene in a patient with t(15:17)". Genes Chromosomes Cancer 6, 133–139,
   PubMed Web of Science ®Google Scholar
• Tong, III. Dong, S„ Geng, JP., 1-luang, W., Wang, Z.Y., Sun, G.L.. Chen, S.J., Chen, Z., Larsen, CI and Berger, R. (1992) "Molecular rearrangements of the MYL gene in acute promyelocytic leukemia (APL, M3) define a breakpoint cluster region as well as some molecular variants", Oncogene 7, 311–316.
   PubMed Web of Science ®Google Scholar
• Zelent, A., Guidez, E, Melnick, A., Waxman, S. and Licht, 1.D. (2001) "Translocations of the RARalpha gene in acute promyelo-cytic leukemia", Oncogene 20, 7186–7203.
   Google Scholar
• Dong, S., Qiu, .1., Stenoien, DL., Brinkley, W.R., Mancini, MA. and Tweardy, DJ. (2003) "Essential role for the dimerization domain of NuMA-RARalpha in its oncogenic activities and localization to NuMA sites within the nucleus". Oncogene 22, 858–868.
   PubMed Web of Science ®Google Scholar
• Dong, S. and Tweardy, D.J. (2002) "Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways", Blood 99, 2637–2646.
   PubMed Web of Science ®Google Scholar
• Dong, S., Zhu, J., Reid, A., Strutt, P., Guides, F., Zhong, HI, Wang, Z.Y., Licht, J., Waxman, S., Chomienne, C., etal. (1996) "Amino-terminal protein—protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein", Proc. Nati Acad. Sci. USA 93, 3624–3629.
   PubMed Web of Science ®Google Scholar
• Melnick, A. and Licht, J.D. (1999) "Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia", Blood 93, 3167–3215.
   PubMed Web of Science ®Google Scholar
• Chambon, P. (1995) 'The molecular and genetic dissection of the retinoid signaling pathway", Recent Frog. Harm. Res. 50, 317–332.
   Web of Science ®Google Scholar
• Chambon, P. (1994) "The retinoid signaling pathway: molecular and genetic analyses", Semin. Cell Biol. 5, 115–125.
   PubMedGoogle Scholar
• Chambon, P. (1996) "A decade of molecular biology of retinoic acid receptors", FASEB J. 10, 940–954.
   PubMed Web of Science ®Google Scholar
• Chen, J.D. and Li, H. (1998) "Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors", CM. Rev. Eukaryor Gene, Expr 8, 169–190.
   PubMed Web of Science ®Google Scholar
• Collins, S.J. (2002) "The role of retinoids and retinoic acid receptors in normal hernatopoiesis", Leukemia 16, 1896–1905.
   PubMed Web of Science ®Google Scholar
• Lin, R.J. and Evans, R.M. (2000) "Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers", Mot Cell 5, 821–830.
   PubMed Web of Science ®Google Scholar
• Lin, R.J., Nagy, L„ Inoue, S., Shao, W., Miller, W.H., Jr and Evans. R.M. (1998) "Role of the histone deacetylase complex in acute promyelocytic leukaemia", Nature 391, 811–814.
   Google Scholar
• Breitman, T.R., Selonick, S.E. and Collins, S.J. (1980) "Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid", Proc. Nat! Acad, Sri. USA 77, 2936–2940.
   PubMed Web of Science ®Google Scholar
• Huang, ME., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J. and Wang, Z.Y. (1988) "Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia", Blood 72, 567–572.
   PubMed Web of Science ®Google Scholar
• Degos, L. and Wang, Z.Y. (2001) "All trans retinoic acid in acute promyelocytic leukemia", Oncogene 20, 7140–7145.
   PubMed Web of Science ®Google Scholar
• Darnell, J.E. (1997) "STATs and gene regulation", Science 277, 1630–1635.
   PubMed Web of Science ®Google Scholar
• Brombreg, J. and Darnell, J.E., Jr (2000) "The role of STATs in transcriptional control and their impact on cellular function", Oncogene 19, 2468–2473.
   PubMed Web of Science ®Google Scholar
• Akira, S. (1997) "IL-6-regulated transcription factors", Int. J. Biochent Cell Riot 29, 1401–1418.
   PubMed Web of Science ®Google Scholar
• Zhong, Z., Wen, Z. and Darnell, Jr.. J.E. (1994) "STAT3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6", Science 264, 95–98.
   PubMed Web of Science ®Google Scholar
• Wen, Z., Zhong, Z. and Darnell, J.E., Jr (1995) "Maximal activation of transcription by Statl and Stat3 requires both tyrosine and serine phosphorylation", Cell 82, 241–250.
   Google Scholar
• Schindler, C. and Darnell, J.E., Jr (1995) "Transcriptional responses to polypeptide ligands: the JAK-STAT pathway", A111114, Rea Blochem. 64, 621–651.
   Google Scholar
• Fukada, T., Ohtani, T., Yoshida, Y., Shirogane, T., Nishida, K,, Nakajima, K., Hibi, M. and Hirano, T. (1998) "STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition", EMBO J. 17, 6670–6677.
   PubMed Web of Science ®Google Scholar
• Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M,. Fujitani, Y., Yamaguchi, T., Nakajima. K. and Hirano, T. (1996) "Two signals are necessary for cell proliferation induced by a cytokine receptor gp 130: involvement of STAT3 in anti-apoptosis". Immunity 5, 449–460.
   PubMed Web of Science ®Google Scholar
• Shirogane, T., Fukada, T., Muller, J.M., Shima, D.T., Hibi, M. and Hirano, T. (1999) "Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis", Immunity 11, 709–719.
   PubMed Web of Science ®Google Scholar
• Boeuf, H., Hauss, C., Graeve, F.D., Baran, N. and Kedinger, C. (1997) "Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells", J. Cell. Biol. 138, 1207–1217.
   PubMed Web of Science ®Google Scholar
• Shimozaki, K., Nakajima, K., Hirano, T. and Nagata, S. (1997) "Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells", J. Biol. Chem. 272, 25184–25189.
   PubMed Web of Science ®Google Scholar
• de Koning, J.P., Soede-Bobok, A.A., Ward, AC., Schelen, A.M., Antonissen, C., van Leeuwen, D., Lowenberg, B. and Touw, LP. (2000) "STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor role for the cyclin-dependent kinase inhibitor p27(Kip I )", Oncogene 19, 3290–3298.
   PubMed Web of Science ®Google Scholar
• Chakraborty, A. and Tweardy, D.J. (1998) "STAT3 and G-CSF-induced myeloid differentiation", Leuk. Lymphoma 30, 433–442.
   PubMed Web of Science ®Google Scholar
• Chakraborty, A. and Tweardy, D.J. (1998) "Granulocyte colony-stimulating factor activates a 72-kDa isoform of STAT3 in human neutrophils", J. Leukoc. Biol. 64. 675–680.
   PubMed Web of Science ®Google Scholar
• Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T. and Akira, S. (1997) "Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality". Pwc. Nail Acad. Sci. USA 94, 3801-3804. 1341 Akira, S. (2000) "Roles of STAT3 defined by tissue-specific gene targeting". Oncogene 19, 2607-2611. 1-351 Takeda, T., Kurachi, H., Yamamoto. T., Nishio, Y., Nakatsuji, Y., Morishige, K., Miyake, A. and Murata, Y. (1998) "Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and gIucocorticoid", J. Endocrinol 159, 323–330.
   Web of Science ®Google Scholar
• Takeda, K., Clausen, WE., Kaisho, T., Tsujimura, T., Terada, N., Forster, I. and Akira, S. (1999) "Enhanced Thi activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils", Immunity 10, 39–49.
   PubMed Web of Science ®Google Scholar
• Sano, S., Itarni, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S. and Takeda, J. (1999) "Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis", EMBO J. 18, 4657–4668. 1381 Chapman, R.S., Lourenco, P.C., Tonner, E., Flint, D.J., Seibert, S., Takeda, K., Akira, S., Clarke, A.R. and Watson, C.J. (1999) "Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3", Genes Dev. 13, 2604-2616.
   Google Scholar
• Sano, S., Takahama, Y, Sugawara, T., Kosaka, H., Itami, S., Yoshikawa, K., Miyazaki, J., van Ewijk, W. and Takeda, J. (2001) "Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival", Immunity 15, 261–273.
   PubMed Web of Science ®Google Scholar
• McLemore, KU, Grewal, S., Liu, F., Archambault, A., Poursine-Laurent, J., Haug, J. and Link, D.C. (2001) "STAT-3 activation is required for normal G-CSF-dependent proliferation and granulo-cytic differentiation", Immunity 14, 193–204.
   PubMed Web of Science ®Google Scholar
• Lee, C.K., Raz, R., Gimeno, R., Gertner, R., Wistinghausen, 13,, Takeshita, K., DePinho, R.A. and Levy, D.E. (2002) "STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation", Immunity 17, 63–72.
   PubMed Web of Science ®Google Scholar
• Garcia, R. and Jove, R. (1998) "Activation of STAT transcription factors in oncogenic tyrosine kinase signaling", Biomed. Sci. 5, 79–85.
   Google Scholar
• Yu, CL.. Meyer, D.J., Campbell, OS., Lamer, AC., Carter-Su, C., Schwartz, J. and Jove, R. (1995) "Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Sre oncoprotein", Science 269, 81–83,
   PubMed Web of Science ®Google Scholar
• Turkson, J., Bowman, T.. Garcia, R., Caldenhoven, E„ De Groot, R.P. and Jove, R. (1998) "Stat3 activation by Src induces specific gene regulation and is required for cell transformation", Mol. Cell Biol. 18, 2545–2552.
   PubMed Web of Science ®Google Scholar
• Bromberg, J.F., Horvath, C.M., Besser, D., Lathem, W.W. and Darnell, J.E., Jr (1998) "Stat3 activation is required for cellular transformation by v-src", Mol. Cell Biol. 18, 2553–2558.
   PubMed Web of Science ®Google Scholar
• Bromberg, J.F. and Darnell, I.E., Jr. (1999) "Potential roles of Statl and Stat3 in cellular transformation", Cold Spring Harbor Symp. Quant. Biol. 64, 425–428.
   PubMedGoogle Scholar
• Benekli, M., Xia, Z., Donohue, K.A., Ford, L.A., Pixley, L.A., Baer, M.R., Baumann, H. and Wetzler, M. (2002) "Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival", Blood 99, 252–257.
   PubMed Web of Science ®Google Scholar
• Watson, C.J. and Miller, W.R. (1995) "Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts", Br J. Cancer 71, 840–844.
   PubMed Web of Science ®Google Scholar
• Garcia, R., Yu, C.L., Hudnall, A., Catlett, R., Nelson, K.L., Smithgall, T., Fujita,Ethier, S.P. and Jove, R. (1997)"Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells", Cell Growth Differ 8, 1267–1276. 1501 Sartor, C.1., Dziubinski, MI., Yu, C.L., Jove, R. and Ethier. (1997) "Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells". Cancer Res. 57, 978–987.
   PubMed Web of Science ®Google Scholar
• Mora, L.B., Buettner, R., Seigne, J., Diaz. J., Ahmad, N., Garcia. R.. Bowman, T., Falcone, R.. Fairclough, R., Cantor, A., Muro-Cacho, C., Livingston, S., Karras, J., Pow-Sang. J. and Jove, R. (2002) "Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells", Cancer Res. 62, 6659–6666.
   PubMed Web of Science ®Google Scholar
• Dalton, W.S. and Jove, R. (1999) "Drug resistance in multiple myeioma: approaches to circumvention", Seinin. Oncol 26, 23–27.
   PubMed Web of Science ®Google Scholar
• Grandis, J.R.. Drenning, S.D., Chakraborty, A.. Zhou, MX, Zeng, Q., Pitt, A.S. and Tweardy, D.J. (1998) "Requirement of Stat3 but not Statl activation for epide,nnal growth factor receptor-mediated cell growth in vitro", J. Clin. Inveslig. 102, 1385–1392.
   PubMed Web of Science ®Google Scholar
• Grandis, J.R. and Tweardy, DJ. (1993) "TGF-alpha and EGFR in head and neck cancer", J. Cell. Biocheni.(Suppl. I 7F), 188–191.
   Google Scholar
• Grandis, .1.R,, Perez-Perez. G.1., Yu, V.L., Johnson, J.T. and Blaser. M.J. (1997) "Lack of serologic evidence for Helicobacter pylori infection in head and neck cancer", Head Neck 19, 216–218.
   Google Scholar
• Grandis, J.R., Drenning, S.D., Zeng, Q., Watkins, S.C., Melhem, M.F., Endo, S., Johnson, D.E., Huang, L., He, Y. and Kim, J.D. (2000) "Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo", Proc. Nat! Acad. Sci. USA 97, 4227–4232.
   PubMed Web of Science ®Google Scholar
• Schaefer, T.S., Sanders, L.K. and Nathans, D. (1995) "Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3", Proc. Nati Acad. Sci. USA 92, 9097–9101.
   PubMed Web of Science ®Google Scholar
• Caldenhoven, E., van Dijk, T.B., Solari, R.. Armstrong. J., Raaijmakers, J.A., Lammers, J.W., Koenderman, L. and de Groot, R.P. (1996) "STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription", J. Biol. Chem. 271, 13221–13227.
   PubMed Web of Science ®Google Scholar
• Chakraborty, A., White, S.M., Schaefer, T.S., Ball, ED., Dyer, K.F. and Tweardy, D.J. (1996) "Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells", Blood 88, 2442–2449.
   PubMed Web of Science ®Google Scholar
• Shao, H., Quintero, A.J. and Tweardy, DJ. (2001) "Identification and characterization of cis elements in the STAT3 gene regulating STAT3 alpha and STAT3 beta messenger RNA splicing", Blood 98, 3853–3856.
   PubMed Web of Science ®Google Scholar
• Park, O.K., Schaefer, L.K., Wang, W. and Schaefer, T.S. (2000) "Dimer stability as a determinant of differential DNA binding activity of Stat3 isoforms", J. Biol. Chem. 275, 32244–32249.
   PubMed Web of Science ®Google Scholar
• Minami, M., Inoue, M., Wei, S., Takeda. K., Matsumoto, M., Kishimoto, T. and Akira, S. (1996) "STAT3 activation is a critical step in gp 130-mediated terminal differentiation and growth arrest of a myeloid cell line", Proc. Nat! Acad, Sci. USA 93, 3963–3966.
   PubMed Web of Science ®Google Scholar
• Kawasaki, A., Matsumura, I., Kataoka, Y., Takigawa, E., Nakajima, K. and Kanakura, Y. (2003) "Opposing effects of PML and PML/RAR[alpha] on STAT3 activity", Blood, in press.
   Google Scholar
• Xiao, H., Chung, J., Kao, H.Y. and Yang, Y.C. (2003) "TIP60 is a co-repressor for STAT3", J. Biol. Chem. 278, 11197–11204.
   PubMed Web of Science ®Google Scholar
• Giraud, S., Bienvenu, F., Avril, S., Gascan, H., Heery, D.M. and Coqueret, 0. (2002) "Functional interaction of' STAT3 transcription factor with the coactivator NcoA/SRCla", J. Biol. Chem. 277, 8004–8011.
   Web of Science ®Google Scholar
• Altucci, L, Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C. and Gronemeyer, H. (2001) "Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL", Nat. Med. 7, 680–686.
   PubMed Web of Science ®Google Scholar